TotalMarketCap

Novo Nordisk A S

NVONYSE DenmarkHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$169.058 B

$38.18 -0.21%

Close of 9 Oct 2026

As of 9 Oct 2026, Novo Nordisk A S (NVO) has a market capitalization of $169.1B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

—

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 500 →
  1. #6AstrazenecaAZN$246.2B
  2. #7Abbott LaboratoriesABT$170.4B
  3. #8Novo Nordisk A SNVO$169.1B
  4. #9PfizerPFE$158.6B
  5. #10Vertex PharmaceuticalsVRTX$127.6B

What if Novo Nordisk A S were worth as much as…

Open the what-if tool →

Gold $29.1T

$6,563.30

Per share 172× higher

Bitcoin $1.66T

$375.02

Per share 9.82× higher

Nvidia $5.55T

$1,254.44

Per share 32.9× higher

Or at a round number

$500.0B$1.00T$2.00T$5.00T

Where these numbers come from

Share counts and financials for Novo Nordisk A S are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 10 Oct 2026. Read the methodology.